BRAVIDA Trademark

Trademark Overview

On Monday, April 15, 2024, a trademark application was filed for BRAVIDA with the United States Patent and Trademark Office. The USPTO has given the BRAVIDA trademark a serial number of 79396533. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, April 23, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The BRAVIDA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of pharmaceutical preparations, namely providing medical and scientific research information in the field of clinical trials.
bravida

General Information

Serial Number79396533
Word MarkBRAVIDA
Filing DateMonday, April 15, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, April 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of pharmaceutical preparations, namely providing medical and scientific research information in the field of clinical trials.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 30, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, May 30, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 4, 2024APPLICATION FILING RECEIPT MAILED
Thursday, October 17, 2024ASSIGNED TO EXAMINER
Thursday, October 17, 2024NON-FINAL ACTION WRITTEN
Friday, October 18, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 24, 2024REFUSAL PROCESSED BY MPU
Thursday, October 24, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 9, 2024REFUSAL PROCESSED BY IB
Tuesday, April 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 23, 2025SUSPENSION LETTER WRITTEN
Wednesday, April 23, 2025LETTER OF SUSPENSION E-MAILED
Wednesday, April 23, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 24, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, October 29, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 29, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Related Keywords

bravida information providing research field scientific medical clinical trials preparations pharmaceutical